Filing Details
- Accession Number:
- 0001179110-18-008052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-05 16:08:37
- Reporting Period:
- 2018-06-01
- Accepted Time:
- 2018-06-05 16:08:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1657434 | F. A. Andrew Hack | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-01 | 5,000 | $6.48 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-01 | 5,000 | $39.05 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-06-01 | 2,000 | $6.48 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-01 | 2,000 | $39.86 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-06-04 | 3,000 | $24.60 | 3,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-04 | 3,000 | $37.10 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-01 | 7,000 | $0.00 | 7,000 | $6.48 |
| Common Stock | Stock Option (right to buy) | Disposition | 2018-06-04 | 3,000 | $0.00 | 3,000 | $24.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 41,513 | 2025-09-13 | No | 4 | M | Direct | |
| 67,500 | 2027-02-28 | No | 4 | M | Direct |
Footnotes
- The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on March 30, 2018.
- This transaction was executed in multiple trades at prices ranging from $38.6 to $39.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $39.6 to $40.17. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This option was granted on September 14, 2015 and is scheduled to vest over four years with 25% of the shares having vested on July 1, 2016, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 1, 2019.
- This option was granted on March 1, 2017 and is scheduled to vest over four years in equal monthly installments beginning on March 1, 2017 through March 1, 2021.
Billionaire Hedge Funds
